Variable evidence on metformin efficiency as weight-reducing and antiblastomogenic agent: causes and consequences
The growing interest to metformin in areas beyond the limits of diabetology serves as a stimulus for further evaluation of its effectiveness as a potential modulator of cancer morbidity and obesity epidemic. Gradually detectable differences in the intensity of these effects of the drug can be explai...
Format: | Article |
---|---|
Language: | English |
Published: |
Endocrinology Research Centre
2012-06-01
|
Series: | Ожирение и метаболизм |
Subjects: | |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/6540 |